Pyxis Oncology, Inc. (PYXS) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $53.41M | -55.8% |
| 2024 | $120.75M | -3.9% |
| 2023 | $125.70M | -21.8% |
| 2022 | $160.82M | -38.5% |
| 2021 | $261.31M | +1770.3% |
| 2020 | -$15.64M | -444.4% |
| 2019 | -$2.87M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $53.41M | -55.8% |
| 2024 | $120.75M | -3.9% |
| 2023 | $125.70M | -21.8% |
| 2022 | $160.82M | -38.5% |
| 2021 | $261.31M | +1770.3% |
| 2020 | -$15.64M | -444.4% |
| 2019 | -$2.87M | — |